Loading asset research
Champions Oncology Inc. Common Stock
CSBRNasdaq · USD · StocksQuote as of · Exchange session not verified$5.10
0.00%
Today
CSBR
Loading 1D prices…
Market cap
$71M
Volume
10.1K
52w high
$8.7452w low
$4.83Company profile
Champions Oncology Inc. Common Stock
Champions Oncology, Inc., a technology-enabled research company, provides technology solutions for drug discovery and development in the United States. The company provides personalized cancer care based upon the implantation of human tumors in immune-deficient mice through TumorGraft Technology Platform. It also offers translational oncology solutions that utilizes its technology platform to provide research services that assist in the drug development process of pharmaceutical and biotechnology companies. In addition, the company offers Lumin Bioinformatics, an oncology data-driven software program which contains comprehensive information derived from research services and clinical studies. It markets its products through internet and sales force to pharmaceutical and biotechnology companies. The company was formerly known as Champions Biotechnology, Inc. and changed its name to Champions Oncology, Inc. in April 2011. Champions Oncology, Inc. was incorporated in 1985 and is headquartered in Hackensack, New Jersey.
Sector
Health Care
Industry
Biological Products, (No Diagnostic Substances)
Exchange
Nasdaq
Display currency
USD
Location
BALTIMORE, MD, United States
Employees
214
Fiscal year end
0430
CIK
771856
Session & valuation
Open$5.17
Previous close$5.10
Day high$5.23
Day low$5.00
30-day avg. volume10K
Outstanding shares13.9M
Diluted EPS-$0.08
Latest annual period
P/E (trailing)-63.75
P/E (forward)51.00
Price / book17.96
Beta0.40
Dividend yield—
Deterministic peer set
Companies with SEC SIC 2836
Exact regulatory industry matches, ranked by nearest market capitalization.
| Company | Market cap | Revenue | Net margin | Diluted EPS | Today | Consensus |
|---|---|---|---|---|---|---|
| OKYOOKYO Pharma Limited Ordinary Shares | $73.5M | $0.00 | — | -$0.24 | -2.80% | Buy |
| BSEMBioStem Technologies Inc. Common Stock | $76.9M | $301.8M | +10.56% | $1.47 | +3.23% | Buy |
| LONALeonaBio Inc. Common Stock | $65.2M | $0.00 | — | -$24.70 | +0.87% | Buy |
| KLRSKalaris Therapeutics Inc. Common Stock | $80.5M | $0.00 | — | -$2.85 | +2.42% | Buy |
| INMBINmune Bio Inc. Common stock | $61.6M | $50K | -92000.00% | -$1.86 | -3.90% | Buy |